Company intelligence / Profile preview

Ansa Biotechnologies

Emeryville, California, United Statesansabio.com ↗
Ownership
Private
Employees
~72
Development stage
Commercial
01

Overview

Ansa Biotechnologies has developed a proprietary enzymatic method for synthesizing long and complex custom DNA sequences. Their platform overcomes the length and complexity limitations of traditional chemical synthesis methods. The company now offers clonal synthetic genes up to at least 50 kb through an early access program. Their service has been validated by leading academic labs and industry partners for rapid delivery of highly accurate constructs that were previously considered too difficult or impossible to synthesize using legacy approaches.

Therapeutic areas
Other
Modalities
Synthetic oligonucleotideDNA synthesis reagent/service (enabling technology for gene therapy, cell therapy, synthetic biology)
Industry
Non-Drug Biotech
02

Partnerships

Enoda CellworksStanford University’s Gao laboratoryGeorge Church at Harvard/MIT

Beyond the preview

Go deeper on Ansa Biotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ansa Biotechnologies.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call